We are making coffee for caffeine sensitive people. We do this by producing the world's first caffeine replacement, paraxanthine. It's better than caffeine at waking you up and causes fewer side effects, like anxiety and jitteriness.
Jeffrey Dietrich received his Ph.D. in BioEngineering from UC-Berkeley working in Jay Keasling’s lab to develop new biomanufacturing technologies. Jeffrey then co-founded and was CTO at Lygos (YC W16), which raised over $40MM in equity financing and $10MM in Federal awards to commercialize industrial biochemicals. He has also served on advisory boards for Department of Energy- and National Science Foundation-backed institutions and is an inventor on 17 patents or patent applications.